Diagnosis. Osteoporosis, persistent after 12 years of hormone replacement therapy, and celiac disease. Management. The patient was initially treated for bone loss with postmenopausal hormone ...
The sequential administration of PTH and a bisphosphonate induces better BMD responses than any other treatment given either alone or in combination, but PTH therapy is inconvenient and costly.
the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...
Long-term bisphosphonate treatment of postmenopausal osteoporosis is associated with reduction of bone turnover and might, therefore, have deleterious adverse effects on the repair of microdamage ...
It's not easy being a woman. Just look at the statistics. Women are more likely to have such debilitating conditions as osteoporosis, migraines, Alzheimer disease, depression, multiple sclerosis, and ...